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Abstract. Although primary hyperparathyroidism and malignant diseases account for approximately 90% of the
causes of hypercalcemia, they could occur in association with granulomatous diseases such as tuberculosis or sarcoidosis,
especially in developing countries. Hepatic tuberculosis is difficult to diagnosis without suspicion in cases with normal
findings on chest radiographs. We report a 70-year-old woman who presented with hypercalcemia due to hepatic
tuberculosis. The diagnosis was made by a computed tomography scan and laparoscopic evaluation. After treatment with
anti-tuberculosis medication, her hypercalcemia resolved. Increased vitamin D synthesis by activated macrophages in the
granuloma tissue is the major mechanism of hypercalcemia in tuberculosis.
INTRODUCTION
Hypercalcemia is known to be associated with chronic
granulomatous diseases, which include sarcoidosis, tubercu-
losis, fungal granuloma, berylliosis, and lymphoma. The inci-
dence of hypercalcemia in active tuberculosis is 15% in Hong
Kong, 16% in India, 25% in Greece, 28% in the United
States, and 51% in Australia.1,2 Incidences of hypercalcemia
in tuberculosis are different among countries because of dif-
ferences in vitamin D and calcium intake, amount of sun
exposure, prevalence of tuberculosis, and various laboratory
diagnostic criteria for hypercalcemia.3 Hepatic tuberculosis is
considered to be a rare disease. The diagnosis is often over-
looked because hepatic tuberculosis can have a relatively
nonspecific clinical presentation. We report on a 70-year-old
woman who presented with hypercalcemia due to hepatic tu-
berculosis.
CASE REPORT
A 70-year-old woman was admitted to Yonsei University
Severance Hospital with generalized weakness and lethargy
over a period of eight months. She reported no personal or
family history of tuberculosis. On examination, she had an
obvious weight loss of 6 kg during the last 8 months, but the
results of the physical examination were normal. Laboratory
tests showed the following results: white blood cell count 
5,590/mm3, hemoglobin level  9.1 g/dL, and platelet count
 236,000/mm3. The total calcium level was elevated (13.5
mg/dL) and the ionized calcium level was also elevated (6.67
mg/dL). The phosphate level was within the normal range.
The blood urea nitrogen level (33.4 mg/dL) and creatinine
concentration (1.6 mg/dL) were mildly elevated. Total pro-
tein, albumin, and alkaline phosphatase levels were normal.
The parathyroid hormone (PTH) level was slightly de-
creased (6.38 g/mL). The PTH-related peptide (PTH-rp)
level was normal. Thyroid function test results were normal.
The carcinoembryonic antigen and -fetoprotein levels were
within normal ranges. A 24-hour urine study showed that
calcium excretion and phosphate excretion were within nor-
mal limits. The results of a chest radiograph were normal.
Intravenous hydration with normal saline was started on ad-
mission, and serum urea nitrogen and creatinine levels de-
creased to be 12.8 and 1.2 mg/dL, respectively, but the serum
calcium level remained slightly elevated above the upper nor-
mal limit. A bone marrow study showed 20% cellularity in the
marrow with a nearly normal myeloid cell to erythroid cell
ratio, full maturation of myeloid and erythroid cells, and an
adequate number of megakaryocytes without aggregates of
plasma cells. Primary hyperparathyroidism, hypercalcemia of
malignancy, and multiple myeloma were excluded. Abdomen
computed tomography showed multiple, small, ill-defined,
hypodense lesions in both the liver and spleen (Figure 1). A
laparoscopic biopsy was performed. Pathologic examination
showed chronic granulomatous inflammation with multinu-
cleated giant cells and caseating necrosis, compatible with
tuberculosis (Figure 2). The results of Ziehl-Neelsen staining
of the granuloma for acid-fast bacilli were negative. Histo-
logically, the presence of a caseating granuloma is diagnos-
tic.4–6
The patient was diagnosed as having hepatic tuberculosis
with hypercalcemia. Anti-tuberculosis chemotherapy includ-
ing daily isoniazid (300 mg), rifampin (450 mg), ethambutol
(800 mg), pyrazinamide (1 gram), and pyridoxine (50 mg) was
initiated. Within one week of the initiation of therapy, the
serum calcium level dramatically decreased to 9.4 mg/dL, and
the patient showed a markedly improved sense of well-being.
Pyrazinamide was discontinued after two months of therapy
while the rest of medications were continued for 12 months
without recurrence. Over the next six months, a follow-up
abdominal computed tomography scan showed resolution of
her previous lesions in the liver and spleen.
FIGURE 1. Abdominal computed tomography scan of the patient.
Multiple small hypodense lesions with ill-defined margin are present
in the liver and spleen.
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DISCUSSION
Hypercalcemia is one of the most common metabolic dis-
orders and its major causes are malignancy and primary hy-
perparathyroidism. One study reported that hypercalcemia in
hospitalized patients was due mainly to malignancy, while
hypercalcemia in outpatients was most commonly due to pri-
mary hyperparathyroidism.7 Malignancy induces hypercalce-
mia in 10−20% of all cancer patients through PTH-rp or di-
rect osteolytic bone metastasis. Other etiologies that give rise
to hypercalcemia are thiazide diuretics, open heart surgery,
chronic renal failure, thyrotoxicosis, lithium therapy, immo-
bilization, and chronic granulomatous diseases. The main
cause of hypercalcemia in Asian countries is cancer, followed
by tuberculosis.8 When hypercalcemia is severe, it can cause
vomiting, polyuria, dehydration, and renal impairment.
Hypercalcemia in chronic renal failure is due to vitamin D
medication for preventing secondary hyperparathyroidism
and use of calcium carbonate as a phosphorus binder. Hypo-
calcemia is usually seen in advanced renal failure. The mecha-
nism of hypercalcemia in granulomatous diseases is deregu-
lated production of 1, 25(OH)2D3 in activated macrophages
and granuloma tissues.9 The 1, 25(OH)2D3 synthesized in T
lymphocyte participates in cellular immunity and plays an
important role in the immune reaction against mycobacteria.
Normally, vitamin D synthesized in T lymphocytes reinforces
macrophages to kill mycobacteria without affecting calcium
metabolism. Large amounts of 1, 25(OH)2D3 production
would result in hypercalcemia.10 However, impairment of cal-
cium metabolism is not always associated with increased se-
rum levels of 1, 25(OH)2D3, and not all tuberculosis patients
develop hypercalcemia. The development of hypercalcemia
in tuberculous patients also depends partially on dietary cal-
cium intake. The other determining factor is the difference in
effectiveness of 25(OH) D3 synthesized from 7-dehydrocho-
lesterol in skin. Ultraviolet light is essential in this reaction. In
tropical areas where there is a large amount of sun exposure,
the concentration of 25(OH) D3 increases with an increase in
active vitamin D synthesis. This theory is supported by the
fact that incidence of tuberculous hypercalcemia is high in
areas with large amount of sun exposure such as Australia
and Malaysia.11,12 Most cases of hypercalcemia with tubercu-
losis are asymptomatic or mild. Active tuberculosis is more
likely to be associated with severe hypercalcemia.3 It is re-
ported that after 18−24 months of anti-tuberculosis medica-
tion, 85% of the patients showed complete remission. Gen-
erally, isoniazid, streptomycin, and ethambutol are known to
be less harmful to the liver and are used in hepatic tubercu-
losis patients during the first 4−6 weeks. Poor prognostic fac-
tors of hepatic tuberculosis include an age less than 20 years
old, acute hepatic involvement, chronic renal failure, diabe-
tes, alcohol intoxication, steroid medication, prolonged pro-
thrombin time, and severe caseous necrosis.13
In conclusion, hypercalcemia is a well-recognized compli-
cation of active pulmonary tuberculosis. However, one should
also consider hepatic tuberculosis without pulmonary tuber-
culosis as a cause of hypercalcemia.
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FIGURE 2. Microscopic view of the liver of the patient, showing
features of tuberculosis with chronic granulomatous inflammation
with caseation and giant cells (hematoxylin and eosin stained, mag-
nifications × 100 in A and × 200 in B).
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